Since EpCAM knockdown and EpAb2-6 treatment disrupted cancer cell growth and induced cancer cell apoptosis in vitro, we investigated whether EpAb2-6 could be used to directly inhibit tumor growth in vivo. This evidence concerns the gene EPCAM and neoplasm.